News ResMed Inc. Australian S.E.

Equities

Delayed Australian S.E. Other stock markets 11:57:31 2024-05-21 pm EDT			5-day change	1st Jan Change
32.69 ^AUD	-0.34%		-0.03%	+28.50%

May. 14	Transcript : ResMed Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 04:05 PM
May. 10	Resmed Insider Sold Shares Worth $2,747,810, According to a Recent SEC Filing	MT

ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy	May. 16	GL
Transcript : ResMed Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 04:05 PM	May. 14
Resmed Insider Sold Shares Worth $2,747,810, According to a Recent SEC Filing	May. 10	MT
Resmed Insider Sold Shares Worth $3,178,815, According to a Recent SEC Filing	May. 09	MT
Ex-dividend day	May. 07	FA
ResMed Announces Participation in the RBCCM Global Healthcare Conference	May. 07	GL
ResMed : Q3 2024 ResMed Earnings Results Webcast Transcript	Apr. 29	PU
Morgans rates RMD as Add	Apr. 28	AQ
ResMed Silences The Doubters	Apr. 28	AQ
Sector Update: Health Care Stocks Edge Higher Late Afternoon	Apr. 26	MT
Top Midday Gainers	Apr. 26	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	Apr. 26	MT
In-Line Inflation Data, Tech Earnings Lift US Equity Indexes	Apr. 26	MT
Sector Update: Health Care	Apr. 26	MT
KeyBanc Adjusts Price Target on ResMed to $238 From $227	Apr. 26	MT
ResMed's Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Up Over 17%	Apr. 26	MT
Jefferies Adjusts Price Target on ResMed to $180 From $164	Apr. 26	MT
Oppenheimer Adjusts ResMed Price Target to $200 From $205, Maintains Outperform Rating	Apr. 26	MT
JPMorgan Adjusts Price Target on ResMed to $225 From $198	Apr. 26	MT
Mizuho Adjusts Price Target on ResMed to $220 From $215	Apr. 26	MT

No results for this search

ResMed, Inc. continues to make headway in the sleep market

December 11, 2023 at 05:55 am EST